40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 10
00:58 UTC
|
GH
Guardant Health
|
◎ Target | Dan Leonard ★★★★★ #75 | Buy | $175.00→ $225.00+28.6% |
|
Sep 10
00:58 UTC
|
GEMI
Gemini Space Station
|
◎ Target | James Yaro ★★★☆☆ #1379 | Sell | $3.50→ $4.00+14.3% |
|
Sep 10
00:58 UTC
|
FCX
Freeport-McMoRan
|
◎ Target | Bob Brackett ★★★☆☆ #1423 | Market Perform | $50.00→ $47.00-6.0% |
|
Sep 10
00:58 UTC
|
FCH
Funding Circle
|
◎ Target | firm only | Buy | GBX 300→ GBX 308+2.7% |
|
Sep 10
00:58 UTC
|
EXE
Expand Energy
|
◎ Target | John Freeman ★★★★☆ #364 | Strong-Buy | $145.00→ $147.00+1.4% |
|
Sep 10
00:58 UTC
|
EVMN
Evommune
|
◎ Target | Thomas Smith ★★☆☆☆ #2808 | Outperform | $28.00→ $22.00-21.4% |
|
Sep 10
00:58 UTC
|
EVMN
Evommune
|
◎ Target | Brian Abrahams ★★★☆☆ #2084 | Outperform | $29.00→ $21.00-27.6% |
|
Sep 10
00:58 UTC
|
ETOR
eToro Group
|
◎ Target | James Yaro ★★★☆☆ #1379 | Neutral | $32.00→ $36.00+12.5% |
|
Sep 10
00:58 UTC
|
EPR
EPR Properties
|
◎ Target | Anthony Paolone ★★★☆☆ #1303 | Overweight | $62.00→ $65.00+4.8% |
|
Sep 10
00:58 UTC
|
EFSI
Eagle Financial Services
|
◎ Target | Jake Civiello ★★★★★ #178 | Neutral | $40.00→ $46.00+15.0% |
|
Sep 10
00:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Michael Ulz ★☆☆☆☆ #3009 | Overweight | $45.00→ $36.00-20.0% |
|
Sep 10
00:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Brian Skorney ★★☆☆☆ #2404 | Outperform | $30.00→ $26.00-13.3% |
|
Sep 10
00:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Luca Issi ★★★☆☆ #1493 | Outperform | $35.00→ $30.00-14.3% |
|
Sep 10
00:58 UTC
|
DNLM
Dunelm Group
|
◎ Target | firm only | Overweight | GBX 1,225→ GBX 1,050-14.3% |
|
Sep 10
00:58 UTC
|
DNLM
Dunelm Group
|
◎ Target | firm only | Buy | GBX 1,050→ GBX 1,000-4.8% |
|
Sep 10
00:58 UTC
|
DEI
Douglas Emmett
|
◎ Target | Anthony Paolone ★★★☆☆ #1303 | Neutral | $15.00→ $16.00+6.7% |
|
Sep 10
00:58 UTC
|
CRH
CRH
|
◎ Target | Timna Tanners ★★★☆☆ #1842 | Overweight | $132.00→ $107.00-18.9% |
|
Sep 10
00:58 UTC
|
COIN
Coinbase Global
|
◎ Target | James Yaro ★★★☆☆ #1379 | Buy | $196.00→ $219.00+11.7% |
|
Sep 10
00:58 UTC
|
CNS
Corero Network Security
|
◎ Target | firm only | Buy | GBX 20→ GBX 21+5.0% |
|
Sep 10
00:58 UTC
|
CMC
Commercial Metals
|
◎ Target | Bennett Moore ★★★☆☆ #2037 | Overweight | $86.00→ $83.00-3.5% |
|
Sep 10
00:58 UTC
|
CLF
Cleveland-Cliffs
|
◎ Target | Bennett Moore ★★★☆☆ #2037 | Neutral | $11.00→ $13.00+18.2% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Lance Jessurun not yet tracked | Sec→ r Outperform | $40.00→ $42.00+5.0% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Timothy Chiodo ★★★★★ #295 | Neutral | $28.00→ $31.00+10.7% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Patrick Moley ★★★☆☆ #2189 | Overweight | $35.00→ $40.00+14.3% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1182 | Overweight | $39.00→ $40.00+2.6% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★★★☆☆ #1405 | Overweight | $33.00→ $40.00+21.2% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Joseph Vafi ★☆☆☆☆ #3090 | Buy | $45.00→ $50.00+11.1% |
|
Sep 10
00:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Alex Markgraff ★★☆☆☆ #2874 | Overweight | $33.00→ $40.00+21.2% |
|
Sep 10
00:58 UTC
|
CCC
Computacenter
|
◎ Target | firm only | Buy | GBX 5,300→ GBX 6,500+22.6% |
|
Sep 10
00:58 UTC
|
CASY
Casey's General Stores
|
◎ Target | Irene Nattel ★★★☆☆ #1254 | Sec→ r Perform | $913.00→ $910.00-0.3% |
|
Sep 10
00:58 UTC
|
CASY
Casey's General Stores
|
◎ Target | Edward Kelly ★★★☆☆ #1209 | Overweight | $960.00→ $750.00-21.9% |
|
Sep 10
00:58 UTC
|
CAN
Canaan
|
◎ Target | Kevin Cassidy ★★☆☆☆ #2711 | Buy | $1.30→ $0.75-42.3% |
|
Sep 10
00:58 UTC
|
BXP
BXP
|
◎ Target | Michael Lewis ★★★☆☆ #1488 | Hold | $64.00→ $68.00+6.2% |
|
Sep 10
00:58 UTC
|
BSX
Boston Scientific
|
◎ Target | Marie Thibault ★★★★☆ #850 | Buy | $60.00→ $56.00-6.7% |
|
Sep 10
00:58 UTC
|
BRZE
Braze
|
◎ Target | Brett Huff ★★★☆☆ #2151 | Overweight | $31.00→ $34.00+9.7% |
|
Sep 10
00:58 UTC
|
BRZE
Braze
|
◎ Target | Alexei Gogolev ★★★☆☆ #1237 | Overweight | $35.00→ $34.00-2.9% |
|
Sep 10
00:58 UTC
|
BRZE
Braze
|
◎ Target | Taylor McGinnis ★★★★★ #40 | Buy | $28.00→ $32.00+14.3% |
|
Sep 10
00:58 UTC
|
BRZE
Braze
|
◎ Target | Brian Peterson ★★★☆☆ #1392 | Outperform | $27.00→ $33.00+22.2% |
|
Sep 10
00:58 UTC
|
BRZE
Braze
|
◎ Target | David Hynes ★★★★★ #175 | Buy | $35.00→ $37.00+5.7% |
|
Sep 10
00:58 UTC
|
BLTE
Belite Bio
|
◎ Target | Graig Suvannavejh ★★☆☆☆ #2667 | Outperform | $220.00→ $234.00+6.4% |
|
Sep 10
00:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | John Newman ★★☆☆☆ #2535 | Buy | $23.00→ $20.00-13.0% |
|
Sep 10
00:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Laura Prendergast ★★☆☆☆ #2777 | Buy | $23.00→ $15.00-34.8% |
|
Sep 10
00:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Sean McCutcheon ★★☆☆☆ #2290 | Outperform | $24.00→ $22.00-8.3% |
|
Sep 10
00:58 UTC
|
B
Barrick Mining
|
◎ Target | Bob Brackett ★★★☆☆ #1423 | Outperform | $61.00→ $56.50-7.4% |
|
Sep 10
00:58 UTC
|
APH
Amphenol
|
◎ Target | Joseph Giordano ★★★☆☆ #1117 | Hold | $175.00→ $90.00-48.6% |
|
Sep 10
00:58 UTC
|
APD
Air Products and Chemicals
|
◎ Target | Alexandra Yates ★★★★★ #240 | Buy | $316.00→ $329.00+4.1% |
|
Sep 10
00:58 UTC
|
ADBE
Adobe
|
◎ Target | Parker Lane not yet tracked | Hold | $200.00→ $225.00+12.5% |
|
Sep 10
00:58 UTC
|
ABM
ABM Industries
|
◎ Target | Joshua Chan ★★★☆☆ #1280 | Neutral | $45.00→ $51.50+14.4% |
|
Sep 10
00:58 UTC
|
ABM
ABM Industries
|
◎ Target | Andrew Wittmann ★★★★☆ #656 | Neutral | $48.00→ $53.00+10.4% |
|
Sep 09
22:58 UTC
|
SIG
Signet Jewelers
|
◎ Target | Randal Konik ★★★☆☆ #2048 | Buy | $150.00→ $175.00+16.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.